Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Pass Below 50 Day Moving Average - What's Next?

Key Points

• Bayer shares fell below their 50-day moving average, trading as low as $13.664 and closing near $13.76, down 2.6%.
• Analyst sentiment remains positive: two analysts rate the stock a Strong Buy, five rate it Buy, and one rates it Hold, producing a consensus rating of Buy.
• Bayer exceeded quarterly expectations with $0.29 EPS versus $0.23 forecast and $12.53 billion in revenue versus $12.31 billion expected; full-year 2026 guidance is $1.20–$1.346 EPS.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $13.97 and traded as low as $13.6640. Bayer Aktiengesellschaft shares last traded at $13.76, with a volume of 208,956 shares changing hands.

Wall Street Analyst Weigh In

BAYRY has been the subject of several recent research reports. Zacks Research raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 10th. Jefferies Financial Group upgraded Bayer Aktiengesellschaft to a "hold" rating in a report on Friday, May 29th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Thursday, July 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Bayer Aktiengesellschaft presently has a consensus rating of "Buy".

Bayer Aktiengesellschaft Trading Down 2.6%

The stock has a market cap of $54.08 billion, a price-to-earnings ratio of -26.98, a P/E/G ratio of 2.12 and a beta of 0.56. The business has a 50-day simple moving average of $13.97 and a two-hundred day simple moving average of $12.33. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.67 and a current ratio of 1.04.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.06. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. The business had revenue of $12.53 billion during the quarter, compared to the consensus estimate of $12.31 billion. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. As a group, research analysts forecast that Bayer Aktiengesellschaft will post 1.28 EPS for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863, the company develops and markets products in healthcare and agriculture and serves customers in markets around the world. Bayer's American depositary shares trade over the counter under the symbol BAYRY.

The company operates through three principal areas: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals business develops prescription medicines in areas such as cardiovascular disease, women's health, oncology, neurology and specialty therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.